In human, high expression of HOXA cluster genes, is a hallmark of high-risk, refractory AML, particularly MLLr leukemias [16,20,21,22,23,24] and direct binding of MLL-fusion proteins to HoxA promoter regions results in increased expression of these genes in leukemic models [25]. The gene discussed is KMT2A; the disease is leukemia.